Symbolbild · KI-generiert
Doseology Sciences Inc
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Doseology is a performance-driven innovation company at the intersection of biotechnology and advanced delivery systems, engineering precision-formulated oral stimulants that optimize energy, focus, and cognitive performance. Through science-backed research and cutting-edge formulation technologies, the Company is pioneering next-generation performance solutions that empower consumers to perform at their peak.
Company description as published by the issuer via Canadian Securities Exchange.
Comparable companies
Companies in the Industrials & Manufacturing sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Doseology Sciences Inc | MOOD | CSE | 1 Mio. USD |
| Urban Infrastructure Group Inc. | UIG | TSXV | 1 Mio. USD |
| First Growth Funds Limited | FGFL | CSE | 1 Mio. USD |
| Copland Road Capital Corporation | CRCC | CSE | 1 Mio. USD |
| Tempus Capital Inc. | TEMP | CSE | 1 Mio. USD |
| Advantex Marketing International Inc. | ADX | CSE | 945.943 USD |
| BIOSENTA Inc. | ZRO | CSE | 920.889 USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.